You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Australian Therapeutic Goods Advisory Council
On 16 July 2012, the Australian Government announced that it would establish an Australian Therapeutic Goods Advisory Council (the Council) to provide broad strategic advice to the TGA, with an emphasis on improving communications between the regulator and its key stakeholders.
The establishment of this committee was a key recommendation of the TGA Transparency Review and forms part of the roll-out of the reforms outlined in the plan for the TGA reforms: a blueprint for TGA's future, (the blueprint).
On 16 November 2012, the Parliamentary Secretary for Health and Ageing, The Hon. Catherine King MP announced the membership of the Council to be chaired by Australia's Chief Medical Officer, Professor Chris Baggoley.
Members of the Council were selected for their individual knowledge and extensive experience in areas as diverse as clinical practice, research, industry experience, business management, health consumer issues and public administration.
Terms of reference
The Council is to provide strategic advice to the TGA on:
- matters relating to organisational planning, management initiatives, performance measures and quality improvement, including service standards and benchmarking;
- increasing public awareness of the safe use of therapeutic goods;
- engagement with stakeholders, including consumer health organisations, health practitioner organisations, industry organisations and companies, academia; and
- emerging issues in public health and safety, regulatory policy and processes.